Matrix metalloproteinase- 9 polymorphisms in the diagnosis of prostate cancer. A preliminary experience;Polimorfismos de la metaloproteasa de matriz 9 (MMP-9) en el diagnóstico del carcinoma prostático. Experiencia preliminar

Archivos Espanoles de Urologia

Volumn 63, Issue 2, 2010, Pages 125-132

  Ugarteburu, Rodrigo Gil ^a   Del Fresno, Manuel Rivas ^a   Rodríguez, Iván Gonzálezs ^a   Arriaga, Patricia González ^a   Cima López, Felicitas ^a   Samoano, Ana Fernandez ^a   García, Isabel Fernández ^a   García, Priscila Benito ^a   Fernández, Valentín Muruamendiaraz ^a   Tardón, Adonina ^a  

^a HOSPITAL DE CABUEÑES   (Spain)

Author keywords

Extracellular matrix metalloproteinase 9; Prostate cancer; Prostatic biopsy

Indexed keywords

GELATINASE B;

ADENOCARCINOMA; AGED; ARTICLE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; MIDDLE AGED; PROSTATE TUMOR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS;

EID: 77956220794     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange PH. Screening for prostatic carcinoma with prostate specific antigen. J Urol 1992; 147(3Pt2): 841-845
2. Albertsen PC. Screening for prostate cancer in neither appropriate nor cost-effective. Urol Clin North Am 1996; 23 (4): 521-530
3. Morgia G, Falsperla M, Malaponte G, Madonia M, Indelicat M, Travali S, et al. Matrix metalloproteinase as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer. Urol Res 200; 33(1): 44-50.
4. Zhang L, Shi J, Feng J, Klocker H, Lee C, Zhang J. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer. Prostate cancer prostatic dis. 2004; 7, 327-332
5. Sauer CG, Kappeler A, Späth M, Kaden JJ, Michel MS, Mayer D, et al. Expresion and activity of matrix metalloproteinases -2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients. Virchows Arch 2004; 444(6): 518-526
6. González-Arriaga P, López-Cima MF, Fernández-Somoano A, Pascual T, Marrón MG, Puente XS, et al. Polymorphism +17 C/G in matrix metalloprotease MMP8 decreases lung cancer risk. BMC Cancer. 2008; 19(8):378.
7. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 1994; 151 (6), 1571-1574
8. Park S, Shinohara K, Grossfeld GD, Carroll PR. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol. 2001; 165 (5): 1409-1414
9. Steinbeg DM, Sauvageot J, Piantdosi S, Epstein JL. Correlation of prostate needle biopsyand radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol 1997; 21: 566-576
10. http://www.ncbi.nlm.nih.gov/SNP/Snp-ref.cgi?rs=2250889.HapMap-CEU
11. Awakura Y, Ito N, Nakamura E, Takahashi T, Kotani H, Mikami Y, et al. Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population. Cancer Lett. 241 (2006) 59-.
12. Matsumura S, Oue N, Nakayama H, Kitadai Y, Yoshida K, Yamaguchi Y, et al. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol. 2005;131(1): 19-25 E pub 2004; 30.
13. Wang Y, Fang S, Wei L, Wang R, Jin X, Wen D, et al. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma. Lung Cancer, 2005; 49(2): 155-161
14. Xu E, Xia X, Lu B, Xing X, Huang Q, Ma Y, et al. Association of matrix metalloproteinase-2 and -9 promoter polymorphisms with colorectal cancer in Chinese. Mol Carcinog.(2007) Jun 1.
15. Li Y, Jin X, Kang S, Wang Y, Du H, Zhang J, et al. Polymorphisms in the promoter regions of the matrix metallopretinases -1, -3, -7 and -9 and the risk of epithelial ovarian cancer in China. Gynecol Oncol. 2006; 101: 92-96.
16. Grieu F, Li WQ, Iacopetta B, et al. Genetic polymorphisms in the MMP2 and MMP9 genes and breast cancer phenotype. Breast Cancer Res Treat, 2004; 88: 197-204.
17. Sugimoto M, Yoshida S, Kennedy S, Deguchi M, Ohara N, Maruo T. Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population. J Soc Gynecol Investig. 2006; 13(7):523-529 Epub 2006.
18. Vairaktaris E, Vassiliou S, Nkenke E, Serefoglou Z, Derka S, Tsigris C, et al. A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol. 2007 May 9.
19. Hu Z, Huo X, Lu D, Qian J, Zhou J, Cheny Y, et al. Funcional polymorphisms of matrix metalloprotienase-9 are associated with risk of occurrence and metastasis of lung cancer. Clin Cancer Res 2005; 11(15): 5433-5439